Synthesis and Pharmacological Evaluation of a series of the Agomelatine Analogues as Melatonin MT1/MT2Agonist and 5-HT2CAntagonist

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice

(2013) Domenico De Berardis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I)

(2012) Mohamed Ettaoussi et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain

(2011) Girstaute Dagyte et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Mode of action of agomelatine: Synergy between melatonergic and 5-HT2Creceptors

(2011) Giorgio Racagni et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Sidney H. Kennedy et al.   CNS DRUGS

The Novel Antidepressant Agomelatine Normalizes Hippocampal Neuronal Activity and Promotes Neurogenesis in Chronically Stressed Rats

(2010) Girstautė Dagytė et al.   CNS Neuroscience & Therapeutics

The use of antidepressants in clinical practice: focus on agomelatine

(2010) R. H. McAllister-Williams et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Stephen M. Stahl et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder

(2010) John Zajecka et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Agomelatine: A novel mechanism of antidepressant action involving the melatonergic and the serotonergic system

(2008) Luis San et al.   EUROPEAN PSYCHIATRY

A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR

(2008) Sidney H. Kennedy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY